DK1338596T3 - Fremgangsmåde til fremstilling af antibakterielt middel af carbapenemtypen - Google Patents
Fremgangsmåde til fremstilling af antibakterielt middel af carbapenemtypenInfo
- Publication number
- DK1338596T3 DK1338596T3 DK01982847T DK01982847T DK1338596T3 DK 1338596 T3 DK1338596 T3 DK 1338596T3 DK 01982847 T DK01982847 T DK 01982847T DK 01982847 T DK01982847 T DK 01982847T DK 1338596 T3 DK1338596 T3 DK 1338596T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- antibacterial agent
- carbapenem antibacterial
- carbapenem
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/04—Preparation by forming the ring or condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000352178 | 2000-11-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1338596T3 true DK1338596T3 (da) | 2006-04-18 |
Family
ID=18825114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01982847T DK1338596T3 (da) | 2000-11-20 | 2001-11-19 | Fremgangsmåde til fremstilling af antibakterielt middel af carbapenemtypen |
Country Status (15)
Country | Link |
---|---|
US (2) | US7034150B2 (de) |
EP (1) | EP1338596B1 (de) |
KR (1) | KR100825243B1 (de) |
CN (1) | CN1247581C (de) |
AT (1) | ATE315568T1 (de) |
AU (1) | AU2002214325A1 (de) |
CA (1) | CA2429071A1 (de) |
CY (1) | CY1105598T1 (de) |
DE (1) | DE60116656T2 (de) |
DK (1) | DK1338596T3 (de) |
ES (1) | ES2256311T3 (de) |
HK (1) | HK1054745A1 (de) |
PT (1) | PT1338596E (de) |
TW (1) | TWI290925B (de) |
WO (1) | WO2002040482A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101180271A (zh) * | 2005-03-22 | 2008-05-14 | 第一三共株式会社 | 具有1-烷基吡咯烷结构的碳青霉烯衍生物的制备方法 |
CN101328178B (zh) * | 2007-06-15 | 2010-10-13 | 山东轩竹医药科技有限公司 | 含有噻吩取代的巯基吡咯烷的培南衍生物 |
CN101357919B (zh) * | 2007-06-22 | 2011-06-15 | 山东轩竹医药科技有限公司 | 含有巯基吡咯烷甲酰胺苯磺酰基的培南衍生物 |
CN101333219B (zh) * | 2007-06-26 | 2010-10-13 | 山东轩竹医药科技有限公司 | 含有巯基吡咯烷甲酰胺苯烷基杂环的培南衍生物 |
CN101367812B (zh) * | 2007-06-28 | 2011-04-27 | 山东轩竹医药科技有限公司 | 被巯基吡咯烷甲酰胺基环戊烯酸取代的培南衍生物 |
CN101343271B (zh) * | 2007-07-13 | 2011-01-12 | 山东轩竹医药科技有限公司 | 含有异噁唑烷酮的培南衍生物 |
CN102711872B (zh) * | 2009-12-04 | 2015-02-25 | 贝克顿·迪金森公司 | 用于药物输送装置的笔针移除装置 |
CN102002069A (zh) * | 2010-11-12 | 2011-04-06 | 上海巴迪生物医药科技有限公司 | 一种合成培南类侧链的双环中间体的制备方法及其应用 |
EP2945929B1 (de) * | 2013-01-15 | 2020-01-22 | Merck Patent GmbH | Acylguanidine zur behandlung von arthrose |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4491541A (en) * | 1982-11-10 | 1985-01-01 | Farmitalia Carlo Erba | Peptides |
US4958029A (en) * | 1987-01-13 | 1990-09-18 | Banyu Pharmaceutical Co., Ltd. | Process for the production of isoindoline derivatives, novel intermediates and process for their production |
GB8809736D0 (en) * | 1988-04-25 | 1988-06-02 | Fujisawa Pharmaceutical Co | New cephem compounds & process for preparation thereof |
JP3091297B2 (ja) * | 1992-01-10 | 2000-09-25 | 住友製薬株式会社 | ピロリジン誘導体およびその製造方法 |
EP0882728B1 (de) * | 1995-12-21 | 2002-09-04 | Sankyo Company Limited | 1-methylcarbapenem-derivate |
US5952338A (en) * | 1996-07-05 | 1999-09-14 | Takeda Chemical Industries, Ltd. | Agent for prophylaxis and treatment of disturbance of visual function |
JP2955276B2 (ja) | 1997-06-19 | 1999-10-04 | 三共株式会社 | 1−メチルカルバペネム誘導体を含有する抗菌剤 |
US6063931A (en) | 1997-07-09 | 2000-05-16 | Merck & Co., Inc. | Process for synthesizing carbapenem side chain intermediates |
JP2002504156A (ja) * | 1997-07-09 | 2002-02-05 | メルク エンド カンパニー インコーポレーテッド | カルバペネム側鎖中間体の合成プロセス |
WO2004078195A1 (ja) * | 2003-03-07 | 2004-09-16 | Ajinomoto Co., Inc. | 腸管細胞のインスリン産生細胞への変換誘導剤、及び糖尿病治療剤 |
-
2001
- 2001-11-19 AT AT01982847T patent/ATE315568T1/de active
- 2001-11-19 KR KR1020037006797A patent/KR100825243B1/ko not_active IP Right Cessation
- 2001-11-19 CA CA002429071A patent/CA2429071A1/en not_active Abandoned
- 2001-11-19 EP EP01982847A patent/EP1338596B1/de not_active Expired - Lifetime
- 2001-11-19 CN CNB018220711A patent/CN1247581C/zh not_active Expired - Fee Related
- 2001-11-19 TW TW090128583A patent/TWI290925B/zh not_active IP Right Cessation
- 2001-11-19 DE DE60116656T patent/DE60116656T2/de not_active Expired - Lifetime
- 2001-11-19 PT PT01982847T patent/PT1338596E/pt unknown
- 2001-11-19 DK DK01982847T patent/DK1338596T3/da active
- 2001-11-19 AU AU2002214325A patent/AU2002214325A1/en not_active Abandoned
- 2001-11-19 ES ES01982847T patent/ES2256311T3/es not_active Expired - Lifetime
- 2001-11-19 WO PCT/JP2001/010096 patent/WO2002040482A1/ja active IP Right Grant
-
2003
- 2003-05-14 US US10/438,649 patent/US7034150B2/en not_active Expired - Fee Related
- 2003-09-29 HK HK03107007A patent/HK1054745A1/xx not_active IP Right Cessation
-
2005
- 2005-09-02 US US11/219,394 patent/US7091363B2/en not_active Expired - Fee Related
-
2006
- 2006-04-03 CY CY20061100467T patent/CY1105598T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT1338596E (pt) | 2006-05-31 |
AU2002214325A1 (en) | 2002-05-27 |
ATE315568T1 (de) | 2006-02-15 |
ES2256311T3 (es) | 2006-07-16 |
US20030225055A1 (en) | 2003-12-04 |
EP1338596A4 (de) | 2004-08-04 |
DE60116656T2 (de) | 2006-09-21 |
CN1486316A (zh) | 2004-03-31 |
DE60116656D1 (de) | 2006-04-06 |
TWI290925B (en) | 2007-12-11 |
EP1338596A1 (de) | 2003-08-27 |
CN1247581C (zh) | 2006-03-29 |
EP1338596B1 (de) | 2006-01-11 |
US20060009508A1 (en) | 2006-01-12 |
US7091363B2 (en) | 2006-08-15 |
CY1105598T1 (el) | 2010-07-28 |
US7034150B2 (en) | 2006-04-25 |
HK1054745A1 (en) | 2003-12-12 |
KR20030097793A (ko) | 2003-12-31 |
WO2002040482A1 (fr) | 2002-05-23 |
KR100825243B1 (ko) | 2008-04-25 |
CA2429071A1 (en) | 2002-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2110749T3 (es) | Derivado de azolilamina. | |
FR15C0027I2 (fr) | Derives de pyrazolinone | |
DK0920421T3 (da) | Isoxazolinderivater anvendelige som antimikrobielle midler | |
DE60027015D1 (en) | Pseudoerythromycin-derivate | |
DE60228990D1 (de) | Bicyclische verbindung | |
ES2123873T3 (es) | Pirrolocarbazol. | |
ES2157199T3 (es) | Nuevo procedimiento para la produccion de cefalosporinas y nuevos compuestos intermedios para este procedimiento. | |
DK1338596T3 (da) | Fremgangsmåde til fremstilling af antibakterielt middel af carbapenemtypen | |
EP1251134A4 (de) | Neue carbapenem-derivate als quaternäres salz | |
DE60223227D1 (de) | BenzoÄbÄthiophenderivate und Verfahren zu deren Herstellung | |
AU9025601A (en) | Cephem compounds and esbl-detecting reagents containing the same | |
PT1268475E (pt) | Novos agentes bacterianos de benzosultam-oxazolidinona | |
BR9902096A (pt) | Pitazóis. | |
DK0979822T3 (da) | Fremgangsmåde til fremstilling af 2-carbamoyl-pyridiner | |
DE69706950D1 (de) | Furoindolizine | |
ATE448198T1 (de) | Neue alpha-ketoamidderivate und deren verwendung | |
ATE279417T1 (de) | Neue carbapenem-derivate | |
DK1140932T3 (da) | Derivater af benzo-1,8-naphtyridin | |
GT199400033A (es) | Compuestos antibacteriales (derivados de cefalosporina) | |
DE60103732D1 (de) | Pyrimidinderivate mit antitumor-wirkung |